RKI-1447,
RKI-1447,
1342278-01-6,
1-(3-hydroxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea,
RKI1447,
RKI 1447,
1-[(3-Hydroxyphenyl)methyl]-3-(4-Pyridin-4-Yl-1,3-Thiazol-2-Yl)urea,
C16H14N4O2S,
1-[(3-hydroxyphenyl)methyl]-3-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]urea,
3twj,
compound 5g [PMID 23275831],
GTPL8152,
SCHEMBL2560201,
CHEMBL3218011,
KS-00000XGT,
AOB6177,
EX-A238,
US9221808, 1bo-Mes,
US9221808, 1bo-HCl,
BDBM199250,
HMS3653E17,
US9221808, 1bo,
BCP08076,
FD5032,
MFCD26142658,
s7195,
ZINC72317687,
AKOS025405230,
CS-1632,
SB19472,
NCGC00371153-09,
4CA-1099,
BC600484,
DA-45906,
HY-15755,
QC-10897,
SC-96583,
AB0087838,
FT-0700170,
SW219877-1,
Y1875,
07R,
D03CPB,
ACN-029550,
A3771,
A13067,
RKI-1447, 98%, a potent small molecule inhibitor of ROCK1 and ROCK2 - 10MG 10mg,